Metformin for aging and cancer prevention

Anisimov, 1987, Carcinogenesis and Aging, Vol 2

Anisimov, 2006, Premature ageing prevention: Limitations and perspectives of pharmacological interventions, Current Drugs Targets, 7, 1485, 10.2174/1389450110607011485

Spindler, 2010, Caloric restriction: From soup to nuts, Ageing Res Rev., 9, 324, 10.1016/j.arr.2009.10.003

Anisimov, 2009, Carcinogenesis and aging 20 years after: escaping horizon, Mech Ageing Dev., 13, 105, 10.1016/j.mad.2008.02.004

Walford, 1988, The Retardation of Aging and Disease by Dietary Restriction

Masoro, 2006, Caloric restriction and ageing, controversial issues, J Gerontol Biol Sci., 61, 14, 10.1093/gerona/61.1.14

Bartke, 2009, Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones, J Gerontol A Biol Sci Med Sci., 6, 187

Lane, 1999, Calorie restriction in primates, will it work and how will we know?, J Am Geriatr Soc., 4, 869

Ingram, 2003, Calorie restriction in rhesus monkeys, Exp Gerontol., 3, 35

Kenyon, 2001, A conserved regulatory system for aging, Cell, 10, 165, 10.1016/S0092-8674(01)00306-3

deCabo, 2006, Calorie restriction mimetics: an emerging research field, Aging Cell, 5, 97, 10.1111/j.1474-9726.2006.00202.x

Weindruch, 2006, Will dietary restriction work in primates?, Biogerontology, 7, 169, 10.1007/s10522-006-9007-0

Vandfleteren, 2006, The dietary restriction effect inand humans: is the worm a one-millimeter human?, Biogerontology, 7, 127, 10.1007/s10522-006-9003-4

Goto, 2006, Health span extension by later-life caloric or dietary restriction: a view based on rodent studies, Biogerontology, 7, 135, 10.1007/s10522-006-9011-4

Le Bourg, 2006, Dietary restriction would probably not increase longevity in human being and other species able to leave unsuitable environments, Biogerontology, 7, 149, 10.1007/s10522-006-9014-1

Sohal, 2006, Effects of caloric restriction are species-specific, Biogerontology, 7, 157, 10.1007/s10522-006-9004-3

Kirwood, 2006, Caloric restriction does not enhance longevity in all species and is unlikely to do so in humans, Biogerontology, 7, 165, 10.1007/s10522-006-9006-1

Suzuki, 2006, Caloric restriction and human longevity: what can we learned from the Okinawians?, Biogerontology, 7, 173, 10.1007/s10522-006-9008-z

Yu, 2006, Why calorie restriction would work for human longevity, Biogerontology, 7, 179, 10.1007/s10522-006-9009-y

Garofalo, 2001, A mutantinsulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 29, 107

Johnson, 2002, Transcriptional profile of aging in, Curr Biol., 1, 1566

Kenyon, 2007, DAF-16/FOXO targets genes that regulate tumor growth in, Nat Genet., 3, 1306

Kenyon, 2006, Mutations that increase the life span ofinhibit tumor growth, Science, 31, 971

Ruvkun, 2003, DAF-16 target genes that controllife-span and metabolism, Science, 30, 644

Antebi, 2003, The endocrine regulation of aging by insulin-like signals, Science, 29, 1346

White, 2007, Brain IRS2 signaling coordinates life span and nutrient homeostasis, Science, 31, 369

Holzenberger, 2008, Brain IGF-1 receptors control mammalian groth and life span through a neuroendocrine mechanism, PLoS Biol, 6, e254, 10.1371/journal.pbio.0060254

Choudhury, 2009, Ribosomal protein S6 kinase 1 signaling regulates mammalian life span, Science, 32, 140

Schwartz, 2001, Age-associated accumulation of the Apolipoprotein C-III gene T-455C polymorphism C allele in a Russian population, J Gerontol Biol Sci., 56, B27, 10.1093/gerona/56.1.B27

Varrichio, 1996, Glucose tolerance and insulin action in healthy centenarians, Am J Physiol., 27, E890

Manzella, 2003, Glucose regulation and oxidative stress in healthy centenarians, Exp Gerontol., 3, 137

Dhalla, 1983, Potential oxidative pathways of catecholamine in the formation of lipid peroxides and genesis of heart disease, Adv Exp Biol Med., 16, 391

Soares de Melo Kirzner, 2002, Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion, Gerontology, 4, 401

Ingram, 2002, Biomarkers of caloric rest-ricttion may predict longevity in humans, Science, 29, 811

Mooijaart, 2005, Reduced insulin/inIGF-1 signaling and human longevity, Aging Cell, 4, 79, 10.1111/j.1474-9728.2005.00148.x

Cerami, 2001, Protein glycation, diabetes, and aging, Recent Prog Horm Res, 5, 1

Stoohs, 2000, Hyperinsulinemia, the missing link among oxidative stress and age-related diseases?, Free Radicals Biol Med., 2, 1302

Reaven, 2000, Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols, Am J Clin Nutr., 7, 776

Dilman, 1994, Development, Aging and Disease. A New Rationale for an Intervention

Dilman, 1978, Ageing, metabolic immunodepression and carcinogenesis, Mech Ageing Dev., 8, 153, 10.1016/0047-6374(78)90015-5

Liu, 2002, Colorectal cancer mortality and factors related to the insulin resistance syndrome, Cancer Epidemiol Biomarkers Prev., 1, 385

Peiris, 2002, Insulin: a novel factor in carcinogenesis, Am J Med Sci., 32, 140

Hankinson, 2004, Insulin-like growth factors and neoplasia, Nat Rev Cancer, 4, 505, 10.1038/nrc1387

Pollak, 2007, Insulin-like growth factor-related signaling and cancer development, Recent Results Cancer Res., 17, 49, 10.1007/978-3-540-37696-5_4

Pollak, 2010, Metfromin and other biguanides in oncology: advancing the research agenda, Cancer Prev Res., 3, 1060, 10.1158/1940-6207.CAPR-10-0175

Starke-Reed, 2001, Human implications of caloric restriction's effect on laboratory animals: an overview of opportunities for research, J Gerontol Ser A, 56, 5

Carney, 2001, Caloric restriction mimetics, metabolic intervention, J Gerontol Biol Sci., 56, 20

Blagosklonny, 2006, Aging and immortality. Quasi-programmed senescence and its phamacological inhibition, Cell Cycle, 5, 2087, 10.4161/cc.5.18.3288

Blagosklonny, 2007, An anti-aging drug today: from senescence-promoting genes to anti-aging pill, Drug Discovery Today, 1, 218, 10.1016/j.drudis.2007.01.004

Blagosklonny, 2008, Prevention of cancer by inhibiting aging, Cancer Biol Ther., 7, 1520, 10.4161/cbt.7.10.6663

Blagosklonny, 2009, Validation of anti-aging drugs by treating age-related diseases, Aging, 1, 281, 10.18632/aging.100034

Finch, 2003, Evolutionary medicine, from dwarf model systems to healthy centenarians?, Science, 29, 1342

Muntoni, 1974, Inhibition of fatty acid oxidation by biguanides, implication for metabolic physiopathology, Adv Lipid Res, 1, 311, 10.1016/B978-0-12-024912-1.50014-4

Muntoni, 1999, Metformin and fatty acids, Diabetes Care, 2, 179, 10.2337/diacare.22.1.179

Ostroumova, 1982, Metabolic immunodepression and metabolic immunotherapy, an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances, Oncology, 3, 13

Yevtushenko, 1988, Preliminary evidence on metabolic rehabilitation in cancer patients, Arch Geschwulstforsch, 5, 175

Dilman, 1992, Neuroendocrine System, Metabolism, Immunity and Cancer (Clinical Aspects), 102

Poroshina, 2004, Insulin resistance, its consequences for clinical course of the disease and possibilities of correction in endometrial cancer, J Cancer Res Clin Oncol., 13, 687

Berstein, 2005, Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer, Cancer Lett., 22, 203, 10.1016/j.canlet.2004.11.011

Berstein, 2010, 2010. Modern approach to metabolic rehabilitation of cncer patients: biguanides (phenformin and metformin) and beyond, Future Oncol., 6, 1313, 10.2217/fon.10.87

Berstein, 2010, Biguanides: An Expansion to Practical Oncology (past and present), 144

Dilman, 1971, Age-associated elevation of hypothalamic threshold to feedback control and its role in development, aging and disease, Lancet, 1, 1211, 10.1016/S0140-6736(71)91721-1

Bakaev, 2002, Effect of 1-butylbiguanide hydrochloride on the longevity in the nematoda, Biogerontology, 3, 23

Driscoll, Metformin induces dietary restriction-like state and the oxidative stress response to extendhealthspan via AMPK, LKB1, and SKN-1, PloS ONE, 5, e8758, 10.1371/journal.pone.0008758

Fenyk-Melody, 2001, Role of AMP-activated protein kinase in metvhaism of metformin action, J Clin Invest., 10, 1167

Cantley, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 31, 1642

Anisimov, 1980, Effect of treatment with phenfromin, dyphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice, Gerontology, 2, 241

Franceschi, 2005, Effect of metformin on life span and on the development of spontaneous mamary tumors in HER-2/neu transgenic mice, Exp Gerontol., 4, 685

Romanyukha, 2010, Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors, Cell Cycle, 9, 188, 10.4161/cc.9.1.10407

Semenchenko, 2008, Metformin slows down aging and extends life span of female SHR mice, Cell Cycle, 7, 2769, 10.4161/cc.7.17.6625

Anisimov, 2005, Insulin in aging and cancer: new antidiabetic drug Diabenol as geroprotector and anticarcinogen, Int J Biochem Cell Biol., 3, 1117

Anisimov, Piskunova, Popovich, Zabezhinski, Tyndyk, Egormin, Yurova, Rosenfeld, Semenchenko, Berstein, Kovalenko, Poroshina. Protective effect of metformin on biomarkers of aging, life span and spontaneous tumorigenesis in female but not in male 129/Sv mice. in preparation.

Yashin, 2003, Insulin and longevity: antidiabetic biguanides as geroprotectors, Biogerontology, 4, 297, 10.1023/A:1026299318315

Anisimov, 1980, Effect of buformin and diphenylhydantoin on life span, estrus function and spontaneous tumor incidence in female rats, Vopr Onkol., 6, 42

Allison, 2010, Metformin supplementation and life span in Fischer-344 rats, J Gerontol Biol Sci., 65, 468

Hoyt, 2007, Metformin therapy in a transgenic mouse model of Hungtington's disease, Neurosci Lett., 41, 98

Gavrilova, 1997, Diabenol - new antidiabetic compounds with haemobiological activity, Vestnik Volgograd Med Acad., 2, 47

Spasov, 2002, Synthesis and pharmacological activity of 1- and 10-N-substituted 1(10),2,3,4,-tetrahydropyrimido[1,2-a]benzimidazoles, Chemico-Pharmaceut J., 9, 11

Anisimova, 1999, The effect of compounds with antioxidant properties on thrombocyte functional activity, Eksp Klin Farmakol (Moscow), 1, 38

Spasov, 2003, Benzimidazole derivative inhibition of the mutagenic activity of 2-aminoanthracene, Gig Sanit., 5, 61

Scarpello, 2003, Improving survival with metformin, the evidence base today, Diabetes Metab., 2, S636

Johnson, 2005, Improved clinical outcomes associated with metformin in patients with diabetes and heart failure, Diabetes Care, 2, 2345

Zabezhinski, 2007, Methods of evaluating the effect of pharmacological drugs on aging and life span in mice, Methods Mol Biol., 37, 227

Dilman, 1975, The increase of hypothalamic sensitivity to the inhibition by estrogens induced by the treatment with L-DOPA, diphenyl-hydantoin or phenformin in old rats, Bull Exp Biol Med., 1, 96

Anisimov, 1979, Hypothalamic mechanisms of ageing and of specific age pathology - I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system, Exp Gerontol., 1, 161

Mukhopadhayay, 2001, Follicular Gowrth, Ovulation and Fertilization, Molecular and Clinical Basis, 15

Naftolin, 2003, Estrogen, synaptic plasticity and hypothalamic reproductive aging, Exp Gerontol., 3, 53

Cheung, 2002, Metformin and polycystic ovary syndrome, a literature review, J Obstet Gynecol Can, 2, 393

Jakubowicz, 2002, Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome, Fertil Steril., 7, 209

Velloso, 2001, Effect of age on elements of insulin-signaling pathway in central nervous system of rats, Endocrine, 1, 227

Ochsner, 2002, Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization, Recent Prog Horm Res., 5, 195

Shimokawa, 2002, Anti-aging effects of caloric restriction, Involvement of neuroendocrine adaptation by peripheral signaling, Microsc Res Tech., 5, 317

Maswood, 2002, How does the brain control lifespan?, Ageing Res Rev., 1, 155, 10.1016/S1568-1637(01)00003-4

McCarty, 1994, Longevity effect of chromium picolinate - ‘rejuvenation’ of hypothalamic function?, Medical Hypotheses, 3, 253, 10.1016/0306-9877(94)90076-0

Carrieri, 1998, Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2), Eur J Human Gen., 6, 534, 10.1038/sj.ejhg.5200222

Jeune, 2001, Recent advances in human gene-longevity association studies, Mech Ageing Dev., 12, 909

Haddad, 2000, Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III varable number tandem repeat allels, Diabetes, 4, 126

Hitman, 1992, Central obesity and hyperinsulinemia in women are associated with polymorphism in the 5' flanking region of the human insulin gene, Eur J Clin Invest., 2, 265

Gharani, 1997, Linkage and association of insulin gene VNTR regulatory polymorphysm with polycystic ovary syndrome, Lancet, 34, 986

Nerup, 1990, Polymorphysm in 5' flanking region of human insulin gene. Relationships with atherosclerosis, lipid levels and age in three samples from Denmark, Arteriosclerosis, 1, 372

Menendez, 2010, Metformin and cancer. Doses, mechanisms and the dandelion and hermetic phenomena, Cell Cycle, 9, 1057, 10.4161/cc.9.6.10994

Menendez, 2010, Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells, Curr Mol Med., 1, 674

Iakimenko, 1981, Effect of phenformin, L-DOPA and para-chlorophenylalanine on the immunological reactivity and chemical carcinogenesis in BALB/c mice, Vopr Onkol., 2, 45

Nakajima, 2008, Metformin suppresses intestinal polyp growth inmice, Cancer Sci., 9, 2136

Alessi, 2008, Important role of the LKB1-AMPK pathway in suppressing tumorgenesis in PTEN-deficient mice, Biochem J., 41, 211

Nakajima, 2010, Metfrotmin suppresses azoxymethane-induced colorectal aberrant crypt foci by AMP-activating protein kinase, Mol Carcinogenesis, 4, 662

Mungan, 2009, Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia, Eur J Obstet Gynecol Reprod Biol., 14, 195

Anisimov, 2010, Melatonin and metformin inhibits development of cervico-vaginal tumors induced by benzo(a)pyrene in mice, Morphol. Vedomosti.

Anisimov, 2010, Melatonin and metformin inhibits skin carcinogenesis induced by benzo(a)pyrene in mice, Vopr Onkol., 5, 583

Dennis, 2010, Metformin prevents tobacco carcinogen-induced lung tumorigenesis, Cancer Prev Res., 3, 1066, 10.1158/1940-6207.CAPR-10-0055

Alexandrov, 1974, On effect of phenformin on induction of mammary gland tumors in rats, Vopr. Oknol., 2, 94

Pliss, 1978, Inhibition of DMBA-induced carcinogenesis by phenformin in the mammary gland of rats, Arch. Geschwulstforsch., 4, 1

Dilman, 1980, Inhibitory effect of phenformin on the development of mammary tumors induced by N-nitrosomethylurea in rats, Exp Onkol., 3, 40

Dilman, 1980, Inhibition of blastomogenic effect of 7,12-dimethylbenz(a)-anthracene in female rats by buformin, diphenylhydantoin, polypeptide pineal extract and L-DOPA, Bull Exp Biol Med., 8, 723

Mazon, 1980, The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats, Carcinogenesis, 1, 975, 10.1093/carcin/1.12.975

Alexandrov, 1985, Influence of anti-carcinogenic agents on the transplacental carcinogenic effect of N-nitroso-N-ethylurea, Bull Exp Biol Med., 10, 73

L'vovich, 1977, Phenformin elimination of the immunodepression caused by 1,2-dimethylhydrazine in rats, Vopr Onkol., 2, 50

Dilman, 1980, Effect of phenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats, Vopr Onkol., 2, 54

Prokudina, 1982, Inhibition by phenformin of the radiation carcinogenesis in female rats, Exp Onkol., 4, 26

Ahlers, 2009, Metformin in chemically-induced mammary carcinogenesis in rats, Neoplasma, 5, 269

Pour, 2001, Prevention of pancreatic cancer induction in hamsters by metformin, Gastroenterology, 12, 1263

LeRoith, 2002, Circulating insulin-like growth factor-1 levels regulate colon cancer growth and metastasis, Cancer Res., 6, 1030

Brancati, 2003, Abnormal glucose tolerance and the risk of cancer death in the United States, Am J Epidemiol., 15, 1092

Huz, 2006, Diabetes mellitus and breast cancer, a retrospective population-based cohort study, Breast Cancer Res Treat., 9, 349

Morris, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 33, 1304

Johnson, 2006, Increased cancer-related mortality for patientrs with type 2 diabetes who use sulfonylurea or insulin, Diabetes Care, 2, 254

Groenier, 2010, Gans ROB and Bilo HJG. Metformin associated with lower cancer mortality in type 2 diabetes, Diabetes Care, 3, 322

Johnson, 2007, Insulin-sensitizing drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome, Cochrane Database Syst Rev., 1, CD005552

Maske, 1971, Handbook of Experimental Pharmacology, 439

Wierusz-Wysocka, 2010, Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin, Expert Rev Mol Diagn., 1, 509, 10.1586/erm.10.22

Thor, 2009, Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro, Cell Cycle, 8, 909, 10.4161/cc.8.6.7933

Thor, 2009, Metformin induces unique biological and molecular responses in triple negative breast cancer cells, Cell Cycle, 8, 2031, 10.4161/cc.8.13.8814

Menendez, 2009, The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy, Ann Oncol., 2, 592

Menendez, 2009, The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells, Cell Cycle, 8, 88, 10.4161/cc.8.1.7499

Trajkovic, 2009, AMP-activated proteinkinase-dependent and -independent mechanisms underlying in vitro antiglioma action of compound C, Biochem Pharmacol., 7, 1684

Fantus, 2006, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res., 6, 10269

Miskimins, 2008, Cell cycle arrest in metformin treated breast cancer cells involves activarion of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1, J Mol Signaling, 3, 18, 10.1186/1750-2187-3-18

Hirano, 2005, Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal, Clinica Chimica Acta, 35, 139

Panidis, 2007, Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome, Metabolism, 5, 129

Reznik, 2007, Effect of metformin on oxidative stress rate in type 2 diabetic patients, Probl Endocrinol., 5, 3

Leverve, 2000, Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J Biol Chem., 27, 223

Halestrap, 2000, Evidence that metfromin exerts it anti-diabetic effects through inhibition of complex 1 of the mithochondrial respioratory chain, Biochem J., 34, 607

Grad, 2004, Thiazolidinediones, like metformin, inhibit respiratory complex I, Diabetes, 5, 1052

Qureshi, 2007, Effect of metformin on clastogenic and biochenical changes induced by adriamycin in Swiss albino mice, Mutat Res., 63, 93

Stith, 2004, Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase, Biochem Pharmacol., 6, 2081

Pégorier, 2001, Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes, Biochem Pharmacol., 6, 439

Teramoto, 2006, Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin, Diabetologia, 4, 1647

Thomas, 2010, Metfromin, independent of AMPK, inhibits mTORC1 in a Rag GTPase-dependent manner, Cell Metab., 1, 390

Spindler, 2006, Use of microarray biomarkers to identify longevity therapeuthics, Aging Cell, 5, 39, 10.1111/j.1474-9726.2006.00194.x

Spindler, 2005, Identification of potential restriction mimetics by microarray profiling, Physiol Genomics, 2, 343

Anisimov, 2003, Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention, Exp Gerontol., 3, 1041, 10.1016/S0531-5565(03)00169-4

Reaven, 2001, Insulin resistance as a predictor of age-related diseases, J Clin Endocrinol Metab., 8, 3574

Pignatelli, 2002, Metformin decreases platelet superoxide anion production in diabetic patients, Diabetes Metab Res Rev, 1, 156

Motta, 2008, Dehydroepiandrosetrone and metformin regulateproliferation of murine T-lymphocytes, Clin. Exp. Immunol., 15, 289

Prieto, 2010, Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway, Kidney Int., 7, 861

Zorov, 2010, Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria, Kidney Int., 7, 841, 10.1038/ki.2010.20

Alhaider, 2009, Assessment of genomic instability in normal and diabetic rats treated with metformin, Chem-Biol Interact., 18, 296

Bergiele, 1998, Therapeutic effect of metfromin on insulin resistance and hyperandrogenism in polycystic ovary syndrome, Eur J Endocrinol., 13, 269

Nelson, 2010, Genetic variationin the murine lifespan response to dietary restriction: from life extension to life shortening, Aging Cell, 9, 92, 10.1111/j.1474-9726.2009.00533.x

Partridge, 2008, Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors, J Clin Oncol., 2, 907

Goodwin, 2008, Insulin in the adjuvant breast cancer setting: A novel therapeutic target for lifestyle and pharmacologic interventions?, J Clin Oncol., 2, 833, 10.1200/JCO.2007.14.7132

Menendez, 2009, Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells, Cell Cycle, 8, 1633, 10.4161/cc.8.10.8406

Greenberg, 2004, Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase, Science, 30, 2011

Blandino, 2009, Metformin, diet and breast cancer: an avenue for chemoprevention, Cell Cycle, 8, 2661, 10.4161/cc.8.16.9226

Solari, 2010, Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging, Biofactors, 3, 377